An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)

NCT07706868 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Systemic Juvenile Idiopathic Arthritis (sJIA)
Adult Onset Still's Disease (AOSD)

Interventions

DRUG: Anakinra (Kineret®)

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]